Ciliary Body Metastasis from Lung Cancer Presenting as Acute Angle- Closure Glaucoma: Two Case Reports
This paper reports two cases of ciliary body metastasis from lung cancer mimicking primary acute angle-closure glaucoma, highlighting the importance of ultrasound biomicroscopy for early detection and cautioning against incisional surgery when intraocular malignancy is suspected due to the poor response to conventional glaucoma therapy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human eye is a complex organ, but for many, its most critical function is simply seeing the world clearly. Behind the colored part of the eye, known as the iris, lies a hidden structure called the ciliary body. This area produces the fluid that keeps the eye inflated and nourished. When cancer from another part of the body, such as the lungs, travels through the bloodstream and settles in the eye, it most often lands in the choroid, a layer behind the retina. However, it can also hide in the ciliary body. Because this spot is tucked away behind the iris, it is invisible during a standard eye exam. When a tumor grows there, it can push the iris forward, blocking the drainage channels for the eye's fluid. This blockage causes pressure to build up rapidly, leading to a condition called acute angle-closure glaucoma, which brings sudden, severe pain and vision loss. Doctors often treat this as a primary eye emergency, but if the underlying cause is a hidden tumor, standard treatments may fail, and the real danger remains undetected.
Two recent cases from Beijing Tongren Eye Center highlight the difficulty of spotting this hidden threat. Researchers documented the experiences of two women who arrived at the hospital in the grip of a severe glaucoma attack. The first was a sixty-three-year-old woman with a known history of lung cancer. She had been managing her disease with targeted medication, and her systemic condition appeared stable. Suddenly, she developed intense pain and blurred vision in her left eye. Her eye pressure was dangerously high, measuring 55.1 mmHg, while her other eye was normal. Standard treatments to lower the pressure did not work. The doctors noticed something unusual: her central eye chamber was deep, which is not typical for a standard glaucoma attack, and they saw small, gray-white bumps on the surface of her iris. To see what was happening behind the iris, they used a specialized ultrasound camera called ultrasound biomicroscopy. This tool revealed a small, irregular mass in the ciliary body that was pushing the iris forward and blocking the drainage angle. Despite the patient's stable cancer history, the eye tumor was a sign that the disease had returned.
The second case involved a sixty-six-year-old woman who arrived with similar symptoms in her right eye: pain, blurred vision, and high pressure. Unlike the first patient, she had no known history of cancer. During her initial exam, doctors also spotted suspicious gray-white nodules on her iris. When the standard pressure-lowering drugs failed to help, they turned to the same ultrasound imaging. The scan showed a much larger, solid mass in the ciliary body, stretching across a significant portion of the eye's inner wall. This tumor was physically displacing the lens and iris, causing the blockage. The discovery of this mass prompted a deeper look into her overall health. A detailed history revealed she had recently been coughing up blood, a symptom she had not mentioned initially. Further scans confirmed she had advanced lung cancer that had spread to her eye. In both instances, the eye symptoms were the first major warning sign of a serious, hidden malignancy.
The researchers found that in both women, the eye tumor was causing the glaucoma by physically crowding the drainage angle or by releasing cells that clogged the system. Because the root cause was a tumor and not a primary eye problem, the usual surgical fixes for glaucoma, which involve creating new drainage pathways, were avoided. Performing such surgery on an eye with an active tumor could risk spreading the cancer cells to other parts of the body. Instead, the medical team focused on lowering the pressure without invasive surgery, using a laser treatment that reduces fluid production, while simultaneously treating the underlying cancer with chemotherapy. The first patient eventually lost vision in the affected eye and developed new tumors in the other eye and her body, while the second patient began systemic treatment for her newly diagnosed cancer.
These cases demonstrate that when a patient presents with a sudden, painful glaucoma attack that does not respond to standard care, or when unusual signs like gray bumps appear on the iris, doctors must look beyond the surface. The ciliary body is a blind spot in routine examinations, but advanced imaging can reveal tumors that are otherwise invisible. Recognizing that a glaucoma attack might be a symptom of a hidden cancer allows for a different, more appropriate treatment path. It prevents unnecessary eye surgeries that could be harmful and ensures that the systemic disease is addressed quickly. The key takeaway is that the eye can be a window not just to vision, but to the presence of a serious illness elsewhere in the body, and seeing what lies behind the iris can be a matter of life and death.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.